Rosa has a degree in Economic Sciences and Business Administration and Management from the University of Barcelona with postgraduate training in Management Development from the IESE Business School and Digital Business from ISDI. She has more than 30 years of recognized experience in positions of financial management responsibility in international companies. And she also has experience auditing in one of the world’s leading consulting companies.
Specifically, she held positions such as Financial Director of the Pharma division and Scientific Area at Esteve Pharmaceuticals, positions of responsibility in the Planning and Financial Analysis area at Sara Lee, Diageo, and Danone Spain and Mexico. On the other hand, she also worked as a Senior Auditor at Deloitte and as the Financial Director of a family office.
Rosa Benet is an expert in both short- and long-term planning and analysis, treasury and investments, tax, accounting, implementation of technological solutions, and auditing. She led multidisciplinary projects in dynamic and fast-growing environments, always obtaining excellent results and meeting deadlines and budget targets. All her experience will be a great added value for IDIBELL.
Benet replaces Magda Martí, who held the position of Managing Director at IDIBELL since September 2016. Gabriel Capellá, Director of IDIBELL, thanked Magda Martí for her dedication in recent years. During that time, she had to lead key transformations for the entity, such as the integration of the Barcelona Regenerative Medicine Center (CMRB) or managing the exceptional situation caused by the COVID-19 health emergency. In this sense, Capellá expressed that the appointment of Benet will be an opportunity to continue the excellent work of Martí by addressing the new challenges that Institute faces.
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.
IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).